Kansai Nerolac wins NCLT approval. November 4 results set Kansai Nerolac stock

Published on 10/20/2026 at 00:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nerolac's Nerofix merger received approval on September 24, 2026. For Kansai Nerolac stock, an INR 5.97 billion expansion follows Q1 revenue.

Merger and results

NCLT approved the Nerofix integration on September 24, 2026.
Q1 FY27 revenue reached INR 23.74 billion and net profit INR 2.28 billion.
Kansai Nerolac's last NSE price was INR 181.46 on October 19, 2026.
The next results review is scheduled for November 4, 2026.

Kansai Nerolac, INE531A01024, Illustration mit AI erstellt.

Kansai Nerolac (ISIN INE531A01024) received approval for its Nerofix merger from the Mumbai Bench of the National Company Law Tribunal on September 24, 2026, according to Sahi Markets. The integration involves no new share issuance because Nerofix is wholly owned, while a November 4 results review gives Kansai Nerolac stock its next dated checkpoint.

The company describes itself as India's second-largest coating company and a market leader in industrial coatings. Its portfolio includes decorative, automotive, industrial, powder and wood coatings, as well as adhesives, waterproofing products and construction chemicals, according to Kansai Nerolac.

Q1 growth meets expansion

Q1 FY27 revenue from operations reached INR 23.74 billion, up 9.79 percent year over year, while net profit rose 5.95 percent to INR 2.28 billion. The same September 2026 report also put the approved capacity expansion at INR 5.97 billion across the Sayakha, Bawal and Hosur facilities, according to Sahi Markets. The combination gives the merger a measurable operating context: the company is integrating an adjacent business while committing capital to production capacity.

What happens before November 4?

The past twelve months provide three dated markers. On August 3, 2026, Kansai Nerolac reported Q1 FY27 revenue of INR 23.74 billion; on September 24, 2026, the NCLT approved the Nerofix scheme. On the same September 24 date, the company announced a November 4, 2026 board meeting to review quarterly and six-month results, as reported by Screener.

Next dates for investors

The next substantiated company date is November 4, 2026, when the board is scheduled to consider unaudited results for the quarter and six months ending September 30, 2026. That release should show whether the Q1 revenue growth rate and the expansion program are carrying into the first half of fiscal year 2027.

Stock stays tied to execution

The last NSE quote stood at INR 181.46 on October 19, 2026 at 3:29 p.m. IST. The same market snapshot showed a market capitalization of INR 146.8 billion and a 52-week range of INR 157.91 to INR 264.00. Those levels place the stock well above its yearly low but below its yearly high, leaving the November results as the next concrete test of earnings execution.